Atherosclerosis is a disease of ageing, and the most common cause of death in the industrialized world. Cell senescence and the therapeutic removal of senescent cells using 'senolytics' are topical areas of science and translational medicine. A new study reports surprising findings on cell senescence and atherosclerosis with important therapeutic implications.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The multifaceted role of the SASP in atherosclerosis: from mechanisms to therapeutic opportunities
Cell & Bioscience Open Access 31 May 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
12 January 2017
In the version of this article initially published online and in print, the red symbol in Figure 1 should be IL-1α, and not IL-1β. The error has been corrected for the HTML and PDF versions of the article.
References
Childs, B. G. et al. Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science 354, 472–477 (2016).
Matthews, C. et al. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ. Res. 99, 156–164 (2006).
Gardner, S. E., Humphry, M., Bennett, M. R. & Clarke, M. C. Senescent vascular smooth muscle cells drive inflammation through an interleukin-1α-dependent senescence-associated secretory phenotype. Arterioscler. Thromb. Vasc. Biol. 35, 1963–1974 (2015).
Hall, B. M. et al. Aging of mice is associated with p16Ink4a- and β-galactosidase- positive macrophage accumulation that can be induced in young mice by senescent cells. Aging (Albany NY) 8, 1294–1315 (2016).
Gil, J. & Withers, D. Ageing: out with the old. Nature 530, 164–165 (2016).
Holdt, L. M. et al. Expression of Chr9p21 genes CDKN2B (p15INK4b), CDKN2A (p16INK4a, 14ARF) and MTAP in human atherosclerotic plaque. Atherosclerosis 214, 264–270 (2011).
Fuentes, L. et al. Downregulation of the tumour suppressor p16INK4A contributes to the polarisation of human macrophages toward an adipose tissue macrophage (ATM)-like phenotype. Diabetologia 54, 3150–3156 (2011).
Cudejko, C. et al. p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages. Blood 118, 2556–2566 (2011).
Roos, C. M. et al. Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice. Aging Cell 15, 973–977 (2016).
Stoneman, V. et al. Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques. Circ. Res. 100, 884–893 (2007).
Acknowledgements
This work was funded by British Heart Foundation Grants RG/13/14/30314, FS/13/3/30038 and RG/16/8/32388, and the Cambridge NIHR Biomedical Research Centre.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Bennett, M., Clarke, M. Killing the old: cell senescence in atherosclerosis. Nat Rev Cardiol 14, 8–9 (2017). https://doi.org/10.1038/nrcardio.2016.195
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2016.195
This article is cited by
-
The multifaceted role of the SASP in atherosclerosis: from mechanisms to therapeutic opportunities
Cell & Bioscience (2022)
-
Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6
Nature Reviews Cardiology (2021)
-
Erratum: Killing the old: cell senescence in atherosclerosis
Nature Reviews Cardiology (2017)